Furthermore, similarity within a modality was very high, such that breast cancer subtypes were largely clustered correctly, especially when looking at MIB-binding profiles that clearly grouped along luminal, HER2+ and triple negative subtypes. The gene discussed is ERBB2; the disease is breast carcinoma.